NTRK2 and pulmonary large cell neuroendocrine carcinoma: It has been reported that the expression of TrkB and BDNF was associated with poor prognosis in non-small cell lung cancer [13] and TrkB/BDNF signaling pathway could be a therapeutic target for pulmonary large cell neuroendocrine carcinoma [14].